Economic Impact of Tranexamic Acid in Healthy Patients Undergoing Primary Total Hip and Knee Arthroplasty
Authors:
- Blake P. GilletteBGBlake P. Gillette
- Hilal Maradit KremersHKHilal Maradit Kremers
- Christopher M. DuncanCDChristopher M. Duncan
- Hugh M. SmithHSHugh M. Smith
- Robert T. TrousdaleRTRobert T. Trousdale
- Mark W. PagnanoMPMark W. Pagnano
- Rafael J. SierraRSRafael J. Sierra
- 1 September 2013
- journal article
- Published by Elsevier in The Journal of Arthroplasty
- Vol. 28 (8) , 137-139
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Low Risk of Thromboembolic Complications With Tranexamic Acid After Primary Total Hip and Knee ArthroplastyClinical Orthopaedics and Related Research, 2013
- Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion2011
- Antifibrinolytics in Major Orthopaedic SurgeryJournal of the American Academy of Orthopaedic Surgeons, 2010
- Use of antifibrinolytic therapy to reduce transfusion in patients undergoing orthopedic surgery: A systematic review of randomized trialsThrombosis Research, 2009
- The Use of Antifibrinolytic Agents in Total Hip ArthroplastyThe Journal of Arthroplasty, 2006
- Efficacy of aminocaproic, tranexamic acids in the control of bleeding during total knee replacement: a randomized clinical trialBritish Journal of Anaesthesia, 2006
- Tranexamic acid reduces allogeneic red cell transfusions in patients undergoing total knee arthroplasty: results of a meta‐analysis of randomized controlled trialsTransfusion, 2005
- Use of Intravenous Tranexamic Acid to Reduce Allogeneic Blood Transfusion in Total Hip and Knee Arthroplasty: A Meta-analysisAnaesthesia and Intensive Care, 2003
- Blood conservation with tranexamic acid in total hip arthroplasty: A randomized, double-blind study in 40 primary operationsActa Orthopaedica, 2001
- Tranexamic AcidDrugs, 1999